Posch, C., Cholewa, B., Vujic, I., Sanlorenzo, M., Ma, J., Kim, S., . . . Ortiz/Urda, S. (2015). Combined inhibition of MEK and Plk1 has synergistic anti-tumor activity in NRAS mutant melanoma. J Invest Dermatol.
Chicago ZitierstilPosch, C., et al. "Combined Inhibition of MEK and Plk1 Has Synergistic Anti-tumor Activity in NRAS Mutant Melanoma." J Invest Dermatol 2015.
MLA ZitierstilPosch, C., et al. "Combined Inhibition of MEK and Plk1 Has Synergistic Anti-tumor Activity in NRAS Mutant Melanoma." J Invest Dermatol 2015.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.